Pneumococcal Nasopharyngeal Carriage in Infants of Mothers Immunized with 23V Non-conjugate Pneumococcal Polysaccharide Vaccine

被引：9
|
作者：
Lopes, Claudia C. [1 ]
Berezin, Eitan N. [1 ]
Scheffer, Daniel [2 ]
Huziwara, Rosana [1 ]
Sliva, Maria I. [1 ]
Brandao, Angela [3 ]
Guerra, Maria L. [3 ]
Brandileone, Maria C. [3 ]
机构：
[1] Fac Ciencias Med Santa Casa Sao Paulo, Dept Pediat, Sao Paulo, Brazil
[2] Fac Ciencias Med Santa Casa Sao Paulo, Dept Social Med, Sao Paulo, Brazil
[3] Adolfo Lutz Inst, Sao Paulo, Brazil
来源：
JOURNAL OF TROPICAL PEDIATRICS | 2012年 / 58卷 / 05期
关键词：
Streptococcus pneumoniae; 23 valent pneumococcal polysaccharide vaccine; pneumococcal serotypes; SEROTYPE-SPECIFIC HYPORESPONSIVENESS; MATERNAL IMMUNIZATION; COLONIZATION; EPIDEMIOLOGY; DISEASE;
D O I：
10.1093/tropej/fmr107
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
To assess the effects of maternal immunization on pneumococcal colonization in infants, pregnant women were assigned into three groups. The group Pregn Vac received the Pn23V during pregnancy, the group Puerp Vac received vaccine during immediate puerperium and the group No Vac received no vaccine. Nasopharyngeal samples were collected at 3 and 6 months. A total of 150 pregnant women were selected during the prenatal period. The proportion of pneumococcal carriage in at least one evaluation was in group Pregn Vac 22.2% (10/45), group Puerp Vac 23.4% (11/47) and group No Vac 21.2% (10/47), respectively. The most frequently isolated serotype in group Puerp Va and group No Vac was 6B and 6A. In the Pregn Vac, the most important serotype was 19F. Although this study was unable to demonstrate any effect of maternal vaccination in reducing pneumococcal colonization, reduction of colonization for serotype 6B in infants may be an important effect.
引用
收藏
页码：348 / 352
页数：5
相关论文
共 50 条
  • [41] Cost-effectiveness and Health Benefits of Pediatric 23-valent Pneumococcal Polysaccharide Vaccine, 7-valent Pneumococcal Conjugate Vaccine and Forecasting 13-valent Pneumococcal Conjugate Vaccine in China
    Mo, Xiuting
    Tobe, Ruoyan Gai
    Liu, Xiaoyan
    Mori, Rintaro
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (11) : E353 - E361
  • [42] Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine in 23-valent pneumococcal polysaccharide vaccine-naive and previously immunized adult patients with severe chronic kidney disease
    Ulanova, Marina
    Huska, Brenda
    Desbiens, Angele
    Gaultier, Gabrielle N.
    Domonkos, Victoria
    McCready, William G.
    VACCINE, 2021, 39 (04) : 699 - 710
  • [43] Antigen-Specific B-Cell Response to 13-Valent Pneumococcal Conjugate Vaccine in Asplenic Individuals With β-Thalassemia Previously Immunized With 23-Valent Pneumococcal Polysaccharide Vaccine
    Papadatou, Ioanna
    Piperi, Cristina
    Alexandraki, Krystallenia
    Kattamis, Antonis
    Theodoridou, Maria
    Spoulou, Vana
    CLINICAL INFECTIOUS DISEASES, 2014, 59 (06) : 862 - 865
  • [44] Responses to a Conjugate Pneumococcal Vaccine in Preterm Infants Immunized at 2, 3, and 4 Months of Age
    Moss, S. J.
    Fenton, A. C.
    Toomey, J. A.
    Grainger, A. J.
    Smith, J.
    Gennery, A. R.
    CLINICAL AND VACCINE IMMUNOLOGY, 2010, 17 (11) : 1810 - 1816
  • [45] IgG levels against 13-valent pneumococcal conjugate vaccine serotypes in non pneumococcal conjugate vaccine immunized healthy Japanese and intravenous immunoglobulin preparations
    Takahashi, Yoshiko
    Ishiwada, Naruhiko
    Hishiki, Haruka
    Tanaka, Junko
    Akeda, Yukihiro
    Shimojo, Naoki
    Oishi, Kazunori
    Kohno, Yoichi
    JOURNAL OF INFECTION AND CHEMOTHERAPY, 2014, 20 (12) : 794 - 798
  • [46] Dynamics of Streptococcus pneumoniae nasopharyngeal carriage with high heptavalent pneumococcal conjugate vaccine coverage in Central Greece
    Grivea, Ioanna N.
    Tsantouli, Alexandra G.
    Michoula, Aspasia N.
    Syrogiannopoulos, George A.
    VACCINE, 2011, 29 (48) : 8882 - 8887
  • [47] Effectiveness of a 23-valent pneumococcal polysaccharide vaccine and a 13-valent pneumococcal conjugate vaccine among the elderly with chronic respiratory diseases
    Masuda, Toshihiro
    Akamatsu, Taisuke
    Nakatani, Eiji
    Tamura, Kanami
    Takahashi, Shingo
    Tanaka, Yuko
    Watanabe, Hirofumi
    Endo, Yoshinari
    Suzuki, Takahito
    Noguchi, Rie
    Saigusa, Mika
    Yamamoto, Akito
    Shishido, Yuichiro
    Akita, Takefumi
    Morita, Satoru
    Asada, Kazuhiro
    Shirai, Toshihiro
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [48] Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to the 23-valent pneumococcal polysaccharide vaccine in elderly Japanese adults
    Shiramoto, Masanari
    Hanada, Ryuzo
    Juergens, Christine
    Shoji, Yasuko
    Yoshida, Mizuki
    Ballan, Barry
    Cooper, David
    Gruber, William C.
    Scott, Daniel A.
    Schmoele-Thoma, Beate
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (09) : 2198 - 2206
  • [49] Nasopharyngeal Carriage of Streptococcus pneumoniae Among Young Children in Haiti Before Pneumococcal Conjugate Vaccine Introduction
    Watkins, Louise K. Francois
    Milucky, Jennifer L.
    McGee, Lesley
    St-Surin, Florence Sine
    Liu, Pengbo
    Tran, Theresa
    Chochua, Sopio
    Joseph, Gerard
    Shang, Nong
    Juin, Stanley
    Dely, Patrick
    Patel, Roopal
    Van Beneden, Chris A.
    JOURNAL OF INFECTIOUS DISEASES, 2021, 224 : S248 - S257
  • [50] Evaluation of appropriateness of vaccination procedures of the 13-valent pneumococcal conjugate vaccine and the 23-valent pneumococcal polysaccharide vaccine in a hospital setting
    Coleman, Paige
    Sears, Matthew
    Vaichys, Sabina
    Nemecek, Branden
    Guarascio, Anthony
    PHARMACOTHERAPY, 2015, 35 (11): : E305 - E305
12345